Cargando…
Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy
SIMPLE SUMMARY: Axillary status is crucial for determining the correct local and systemic treatment. The possibility of de-escalating axillary surgery in patients with breast cancer undergoing neo-adjuvant chemotherapy is controversial. This is especially true for clinically node-positive (cN+) pati...
Autores principales: | Tinterri, Corrado, Sagona, Andrea, Barbieri, Erika, Di Maria Grimaldi, Simone, Caraceni, Giulia, Ambrogi, Giacomo, Jacobs, Flavia, Biondi, Ersilia, Scardina, Lorenzo, Gentile, Damiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046076/ https://www.ncbi.nlm.nih.gov/pubmed/36980605 http://dx.doi.org/10.3390/cancers15061719 |
Ejemplares similares
-
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023) -
Author response to: Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Gentile, Damiano, et al.
Publicado: (2023) -
The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review
por: Ferrarazzo, Giulia, et al.
Publicado: (2023) -
CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
por: Raschioni, Carlotta, et al.
Publicado: (2018) -
SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?
por: Berasaluce Gómez, Arantxa, et al.
Publicado: (2023)